Catyalyst Pharma (CPRX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.37 --0%
Revenue Growth %: +5.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
JVA, ARDS, FRHC, More
Revenue Growth %: +5.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
JVA, ARDS, FRHC, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX: New Street Research sees 22% upside from proposed IPO price
- Nomura/Instinet Upgrades Mitsubishi Gas Chemical Co Inc (4182:JP) to Buy
- Halma Plc. (HLMA:LN) (HLMAF) PT Lowered to GBp50.10 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
